Farms.com Home   Ag Industry News

Alberta grain bin being used for art purposes

Visitors can go inside the bin for a unique view

Visitors of the Coutts Centre for Western Canadian Heritage near Nanton, Alberta, can go inside a grain bin to see everything - except grain.

Artist Donald Lawrence modified the grain bin into a camera obscura.

Camera obscuras use a lens and mirror to project a live view of its surroundings into a dark room.

“It has the ability to have the lens and mirror that are at the top of it rotate 360 degrees,” Lawrence told Global News. “The lens and the mirror carry inside an image of the surrounding landscape which you see before you on the table in the middle.”

When inside the bin, visitors can see a live, rotating image of outside the bin.

Lawrence said these types of rooms gave researchers a sense of how human eyes work and helped photography advance its technology.



 

“The camera obscura became largely obsolete as a technological scientific device,” Lawrence said.

Jim Coutts, who the centre was named after, was an avid art collector and donated his farm to the University of Lethbridge after passing in 2013.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.